Document is current
Any future updates will be listed below
-
Authors
Xu, Da
Besselink, Swen https://orcid.org/0009-0002-7815-0132
Ramadoss, Gokul N. https://orcid.org/0000-0002-7506-2711
Dierks, Philip H. https://orcid.org/0000-0001-5903-8343
Lubin, Justin P. https://orcid.org/0000-0003-2311-1873
Pattali, Rithu K.
Brim, Jinna I. https://orcid.org/0009-0005-4864-4192
Christenson, Anna E. https://orcid.org/0000-0002-1157-3168
Colias, Peter J.
Ornelas, Izaiah J.
Nguyen, Carolyn D.
Chasins, Sarah E. https://orcid.org/0000-0003-0557-3580
Conklin, Bruce R.
Nuñez, James K. https://orcid.org/0000-0002-7396-6119
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 11 August 2025
First Online: 26 August 2025
Competing interests
: J.K.N. and D.X. have submitted a patent application to U.S. Provisional Patent Office related to the delivery of CRISPR components, as part of this work (application No. 63/686,584). J.K.N. is an inventor of patents related to the CRISPRoff/on technologies, filed by The Regents of the University of California. B.R.C. is a founder of Tenaya Therapeutics and holds equity in the company. The remaining authors declare no competing interests.
